KWALITY PHARMACEUTICALS L (KPL) financials

KWALITY PHARMACEUTICALS L (KPL) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1983, Kwality Pharma is in the business of manufacturing & trading in Pharmaceuticals & allied products[1]

Market Cap: ₹3,525Cr.
Current Price: ₹3,394
Stock P/E: 43.2
ROE: 22.5%
ROCE: 23.9%
Book Value: ₹321
Dividend Yield: 0.00%
52W High / Low: ₹3,949/829

In Jun 2026, KWALITY PHARMACEUTICALS L (KPL) reported sales ₹162 Cr and net profit ₹26 Cr.

Annual TTM: sales ₹554 Cr, net profit ₹81 Cr.

Shareholding: Promoters 54.86% (Jun 2026), FIIs 3.13% (Jun 2026), DIIs 0.56% (Jun 2026), Public 41.45% (Jun 2026), No. of Shareholders 13,279% (Jun 2026).

KPL quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	90	84	116	111	111	123	157	162
Expenses	70	67	90	87	86	93	118	121
Operating Profit	20	18	26	24	25	30	39	41
OPM %	22%	21%	22%	22%	23%	24%	25%	25%
Other Income	0	1	1	0	1	-0	1	1
Interest	3	2	2	3	3	2	3	3
Depreciation	5	5	5	5	5	5	5	5
Profit before tax	13	11	19	17	18	22	32	34
Tax %	33%	25%	24%	30%	23%	28%	20%	25%
Net Profit	8	9	14	12	14	16	25	26
EPS in Rs	8.18	8.23	13.97	11.50	13.61	15.43	24.37	24.70
Raw PDF	—	—	—	—	—	—	—	—

KPL profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	138	261	456	251	307	370	503	554
Expenses	124	231	284	190	241	290	385	419
Operating Profit	14	29	172	61	67	80	118	135
OPM %	10%	11%	38%	24%	22%	22%	24%	24%
Other Income	4	2	4	-14	-5	2	2	2
Interest	3	3	3	7	10	10	11	11
Depreciation	4	6	11	15	20	18	20	20
Profit before tax	11	22	162	26	31	54	90	106
Tax %	24%	29%	26%	24%	24%	26%	25%	—
Net Profit	8	15	120	19	24	40	67	81
EPS in Rs	8.12	14.86	115.70	18.76	23.11	38.44	64.91	78.11
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

KPL balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10	10	10	10	10	10	10	10
Reserves	28	37	52	172	192	216	255	323
Borrowings	28	35	41	54	90	98	112	130
Other Liabilities	40	53	65	106	71	74	72	132
Total Liabilities	107	135	169	343	364	398	451	596
Fixed Assets	28	42	56	91	120	138	144	154
CWIP	0	0	3	12	14	0	0	17
Investments	8	8	9	4	4	4	4	4
Other Assets	71	86	102	236	226	256	303	421
Total Assets	107	135	169	343	364	398	451	596

KPL cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	12	6	26	59	42	43	53	17
Cash from Investing Activity	-11	-17	-23	-63	-48	-26	-28	-35
Cash from Financing Activity	-2	12	1	6	1	-17	-14	7
Net Cash Flow	-1	1	4	2	-5	-0	10	-11
Free Cash Flow	1	-12	3	4	-4	18	28	-29
CFO/OP	104%	59%	112%	59%	79%	67%	85%	32%

KPL shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	54.82%	54.82%	54.82%	54.82%	54.82%	54.82%	54.87%	54.86%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.50%	2.79%	3.13%
DIIs	0.02%	0.03%	0.32%	0.33%	0.33%	0.33%	0.36%	0.56%
Public	45.15%	45.14%	44.86%	44.86%	44.83%	44.33%	41.99%	41.45%
No. of Shareholders	7,487	8,947	9,420	10,115	11,595	10,709	10,555	13,279

KPL key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	86	80	53	57	107	138	154	204
Inventory Days	34	94	38	97	310	187	167	111
Days Payable	52	96	58	63	117	106	112	144
Cash Conversion Cycle	68	78	33	91	300	219	209	171
Working Capital Days	21	43	25	62	120	103	100	129
ROCE %	21%	18%	26%	97%	18%	16%	18%	24%

KPLUpdated 14 Oct 2026, 23:22

Kwality Pharmaceuticals L

KPLUpdated 14 Oct 2026, 23:22

Market Cap

₹3,525Cr.

Current Price

₹3,394

High / Low

₹3,949/829

Stock P/E

43.2

ROE22.5%

ROCE23.9%

Book Value₹321

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1983, Kwality Pharma is in the business of manufacturing & trading in Pharmaceuticals & allied products[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	67	2	54	0	5	7	25	5	5.25
Sep 2023	70	2	54	0	5	8	24	6	6.03
Dec 2023	78	3	61	1	5	10	21	8	7.42
Mar 2024	92	3	71	-7	5	6	28	4	4.34
Jun 2024	80	2	63	0	4	11	25	8	8.07
Sep 2024	90	3	70	0	5	13	33	8	8.18
Dec 2024	84	2	67	1	5	11	25	9	8.23
Mar 2025	116	2	90	1	5	19	24	14	13.97
Jun 2025	111	3	87	0	5	17	30	12	11.5
Sep 2025	111	3	86	1	5	18	23	14	13.61
Dec 2025	123	2	93	0	5	22	28	16	15.43
Mar 2026	157	3	118	1	5	32	20	25	24.37
Jun 2026	162	3	121	1	5	34	25	26	24.7

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	52	1	49	1	1	2	29	1	1.32
Mar 2016	76	1	70	0	2	3	39	2	1.89
Mar 2017	95	2	86	2	2	6	41	3	3.31
Mar 2018	137	2	125	1	3	8	38	5	4.51
Mar 2019	165	2	149	1	3	11	31	8	7.28
Mar 2020	138	3	124	4	4	11	24	8	8.12
Mar 2021	261	3	231	2	6	22	29	15	14.86
Mar 2022	456	3	284	4	11	162	26	120	115.7
Mar 2023	251	7	190	-14	15	26	24	19	18.76
Mar 2024	307	10	241	-5	20	31	24	24	23.11
Mar 2025	370	10	290	2	18	54	26	40	38.44
Mar 2026	503	11	385	2	20	90	25	67	64.91
TTM	554	11	419	2	20	106	—	81	78.11

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	54.86%
FIIs	3.13%
DIIs	0.56%
Public	41.45%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2023	54.76%	0%	0.01%	45.22%
Dec 2023	54.76%	0%	0.01%	45.22%
Mar 2024	54.82%	0%	0%	45.17%
Jun 2024	54.82%	0%	0%	45.18%
Sep 2024	54.82%	0%	0.02%	45.15%
Dec 2024	54.82%	0%	0.03%	45.14%
Mar 2025	54.82%	0%	0.32%	44.86%
Jun 2025	54.82%	0%	0.33%	44.86%
Sep 2025	54.82%	0%	0.33%	44.83%
Dec 2025	54.82%	0.5%	0.33%	44.33%
Mar 2026	54.87%	2.79%	0.36%	41.99%
Jun 2026	54.86%	3.13%	0.56%	41.45%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	4	15	8	10	38	11	0	4	23	38
Mar 2016	5	18	13	17	52	11	0	5	36	52
Mar 2017	5	21	19	27	72	16	0	7	50	72
Mar 2018	10	21	26	41	98	19	0	9	70	98
Mar 2019	10	28	28	40	107	28	0	8	71	107
Mar 2020	10	37	35	53	135	42	0	8	86	135
Mar 2021	10	52	41	65	169	56	3	9	102	169
Mar 2022	10	172	54	106	343	91	12	4	236	343
Mar 2023	10	192	90	71	364	120	14	4	226	364
Mar 2024	10	216	98	74	398	138	0	4	256	398
Mar 2025	10	255	112	72	451	144	0	4	303	451
Mar 2026	10	323	130	132	596	154	17	4	421	596

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	1	-1	1	0
Mar 2016	-3	-2	5	0
Mar 2017	4	-7	5	1
Mar 2018	0	-6	5	-1
Mar 2019	12	-11	-2	-1
Mar 2020	6	-17	12	1
Mar 2021	26	-23	1	4
Mar 2022	59	-63	6	2
Mar 2023	42	-48	1	-5
Mar 2024	43	-26	-17	0
Mar 2025	53	-28	-14	10
Mar 2026	17	-35	7	-11

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	63	95	87	99	86	80	53	57	107	138	154	204
Inventory Days	61	54	72	54	34	94	38	97	310	187	167	111
Days Payable	40	61	67	79	52	96	58	63	117	106	112	144
Cash Conversion Cycle	85	89	92	74	68	78	33	91	300	219	209	171
Working Capital Days	35	41	21	19	21	43	25	62	120	103	100	129
ROCE %	11%	15%	19%	19%	21%	18%	26%	97%	18%	16%	18%	24%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of KWALITY PHARMACEUTICALS L (KPL)?

The reported market capitalisation for KWALITY PHARMACEUTICALS L (KPL) is ₹3,525Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of KPL?

The current price shown for KWALITY PHARMACEUTICALS L (KPL) on Fincrux is ₹3,394 with a 52-week high/low of ₹3,949/829.

What is the P/E ratio of KWALITY PHARMACEUTICALS L (KPL)?

The stock P/E for KWALITY PHARMACEUTICALS L (KPL) is 43.2 on Fincrux, with ROE at 22.5% and ROCE at 23.9%.

What were KPL latest quarterly results?

For Jun 2026, KWALITY PHARMACEUTICALS L (KPL) reported sales ₹162 Cr and net profit ₹26 Cr (figures in ₹ crore unless noted).

What are KPL annual sales and net profit?

For TTM, KWALITY PHARMACEUTICALS L (KPL) shows sales of ₹554 Cr and net profit of ₹81 Cr on the Fincrux profit & loss statement.

Who owns KWALITY PHARMACEUTICALS L (KPL)?

Latest shareholding for KWALITY PHARMACEUTICALS L (KPL) on Fincrux: Promoters 54.86% (Jun 2026), FIIs 3.13% (Jun 2026), DIIs 0.56% (Jun 2026), Public 41.45% (Jun 2026), No. of Shareholders 13,279% (Jun 2026).

Where can I find KWALITY PHARMACEUTICALS L (KPL) financials?

KWALITY PHARMACEUTICALS L (KPL) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show KPL balance sheet and cash flow?

Yes. The KWALITY PHARMACEUTICALS L (KPL) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 14 October 2026 at 23:22